Departments of Internal Medicine, Dong-A University College of Medicine, Busan 602-715, Korea.
Departments of Thoracic and Cardiovascular Surgery, Dong-A University College of Medicine, Busan 602-715, Korea.
J Thorac Dis. 2013 Dec;5(6):737-44. doi: 10.3978/j.issn.2072-1439.2013.11.23.
Long-term cancer survival results in increasing numbers of multiple primary malignancies in one person, which represents growing clinical challenge in patients with lung cancer. This study was intended to assess the incidence rate, temporal relationship, and characteristics of additional primary malignancies (APM) in Korean patients with non-small cell lung cancer (NSCLC).
We reviewed all 632 NSCLCs (313 adenocarcinomas, 276 squamous cell carcinomas, and 43 other NSCLCs) patients who underwent curative resection of NSCLC at the Dong-A University Medical Center from January 1991 to December 2009. We used the hospital information system and medical record to collect data about these patients and their tumors. In the data base, the following parameters were recorded: patient's demographics (age, gender and smoking habit), time interval between the diagnosis of the NSCLC and APM, NSCLC characteristics (date of diagnosis, histology, TNM staging, operative details, and survival) and characteristics of APM (site of tumor, date of diagnosis, histology, TNM staging, operative details, and survival).
Eighty-one (12.8%) of the 632 patients with NSCLC had APMs. Thirty-three patients (40.8%) had APM in their history [occurring earlier than six months or more before NSCLC diagnosis; prior (P) group], 18 patients (22.2%) were diagnosed with an APM synchronously [diagnosed within six months before or after NSCLC; synchronous (S) group], and the remaining 30 patients (37.0%) were diagnosed with an APM during the follow-up period [occurring six months or more after NSCLC diagnosis; metachronous (M) group]. The second primary malignancy occurred most often two to five years in both P group (39.4%) and M group (36.7%). The most frequent APM was stomach cancer (25.0%), followed by colorectal cancer (19.0%), and thyroid cancer (10.7%). Interestingly, we found difference in the incidence of APM between different NSCLC histotypes. In the adenocarcinoma group, colorectal cancer was the most frequently discovered [12 of 46 events (26.1%)], followed by thyroid cancer [9 of 46 events (19.6%)]. In the squamous cell carcinoma group, stomach cancer occurred most frequently [12 of 36 events (33.3%)].
APMs are commonly seen in patients with NSCLC, either preceding or following its occurrence. Therefore, it is important to recognize the characteristic of NSCLC patients with APM in order to detect the second primary malignancy as early as possible and to achieve a possible cure of disease.
长期的癌症生存导致一个人出现越来越多的多种原发性恶性肿瘤,这在肺癌患者中是一个日益严峻的临床挑战。本研究旨在评估韩国非小细胞肺癌(NSCLC)患者中附加原发性恶性肿瘤(APM)的发病率、时间关系和特征。
我们回顾了 1991 年 1 月至 2009 年 12 月期间在东亚大学医学中心接受 NSCLC 根治性切除术的 632 例 NSCLC(313 例腺癌、276 例鳞状细胞癌和 43 例其他 NSCLC)患者的所有资料。我们使用医院信息系统和病历收集了这些患者及其肿瘤的相关数据。在数据库中,记录了以下参数:患者的人口统计学特征(年龄、性别和吸烟习惯)、NSCLC 和 APM 之间的时间间隔、NSCLC 特征(诊断日期、组织学、TNM 分期、手术细节和生存情况)和 APM 的特征(肿瘤部位、诊断日期、组织学、TNM 分期、手术细节和生存情况)。
632 例 NSCLC 患者中有 81 例(12.8%)发生了 APM。33 例患者(40.8%)有 APM 病史(发生在 NSCLC 诊断前 6 个月或更早;前组,P 组),18 例患者(22.2%)为同期诊断(在 NSCLC 诊断前 6 个月内或之后诊断;同期组,S 组),30 例患者(37.0%)在随访期间诊断为 APM(在 NSCLC 诊断后 6 个月或更长时间诊断;异时组,M 组)。第二原发恶性肿瘤在 P 组(39.4%)和 M 组(36.7%)中最常发生在 2 至 5 年。最常见的 APM 是胃癌(25.0%),其次是结直肠癌(19.0%)和甲状腺癌(10.7%)。有趣的是,我们发现不同 NSCLC 组织学类型之间 APM 的发生率存在差异。在腺癌组中,最常发现结直肠癌(46 例事件中的 12 例,26.1%),其次是甲状腺癌(46 例事件中的 9 例,19.6%)。在鳞状细胞癌组中,胃癌的发生率最高(36 例事件中的 12 例,33.3%)。
APM 在 NSCLC 患者中较为常见,无论是在 NSCLC 之前还是之后发生。因此,重要的是要认识到有 APM 的 NSCLC 患者的特征,以便尽早发现第二原发恶性肿瘤,从而有可能治愈疾病。